Lender Registers Resale of 375,000 Warrant Shares; No Direct Proceeds to Company

summarizeSummary

A lender, Perceptive Credit Holdings IV, LP, is offering to resell up to 375,000 shares of Biodesix common stock, representing approximately 3.71% of the company's market cap, with no direct proceeds going to Biodesix.

check_boxKey Events · Financing and Capital Events · BDSX

• Resale Offering by Selling Stockholder

  Perceptive Credit Holdings IV, LP is offering to sell up to 375,000 shares of common stock.

• Origin of Shares

  These shares are issuable upon the exercise of warrants granted to Perceptive in connection with credit agreements, with the latest warrant issuance on February 25, 2026.

• Significant Dilution Potential

  The offering represents approximately 3.71% of the company's current market capitalization.

• No Direct Proceeds to Company

  Biodesix will not receive any proceeds from the sale of these shares by the selling stockholder. Proceeds would only come if the warrants are exercised on a cash basis, which is conditional.

auto_awesomeAnalysis · BDSX · Industrial Applications And Services

This filing finalizes the terms for the resale of a significant block of shares by a major lender, Perceptive Credit Holdings IV, LP. The 375,000 shares, originating from warrants issued as part of credit agreements, represent a substantial 3.71% of Biodesix's market capitalization. While the company may receive proceeds if the warrants are exercised on a cash basis, the primary event is the selling stockholder cashing out, which does not directly inject capital into Biodesix and could create downward pressure on the stock due to the increased supply. This follows the S-3 registration filed on May 21, 2026, making the offering active.